Recombinant FLT1 (Icrucumab Biosimilar) antibody

Catalog No. ABIN7597736

This anti-FLT1 (Icrucumab Biosimilar) antibody is a Human Monoclonal antibody detecting FLT1 (Icrucumab Biosimilar) in . Suitable for Human.

Quick Overview for Recombinant FLT1 (Icrucumab Biosimilar) antibody (ABIN7597736)

Target: FLT1 (Icrucumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This FLT1 (Icrucumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-FLT1 (Icrucumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Icrucumab Biosimilar Antibody

Specificity: FLT1, Vascular endothelial growth factor receptor 1, VEGFR1, Vascular permeability factor receptor, FRT, Tyrosine-protein kinase receptor FLT, VEGFR-1, FLT, FLT-1, Tyrosine-protein kinase FRT, Fms-like tyrosine kinase 1

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 2.49 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for FLT1 (Icrucumab Biosimilar)

Target: FLT1 (Icrucumab Biosimilar)

Alternative Name: Icrucumab Biosimilar

Target Type: Biosimilar

Background: FLT1, Vascular endothelial growth factor receptor 1, VEGFR1, Vascular permeability factor receptor, FRT, Tyrosine-protein kinase receptor FLT, VEGFR-1, FLT, FLT-1, Tyrosine-protein kinase FRT, Fms-like tyrosine kinase 1

UniProt: P17948

CAS-No: 1024603-92-6